GLP-1s are changing healthcare. Here’s how.
HOME | RESOURCES | EVENTS | SUBSCRIBE TRENDING ARTICLES CMS goes live with GLP-1 Bridge program for Part D beneficiaries CMS has officially launched its GLP-1 Bridge program, giving eligible Medicare Part D beneficiaries access to certain weight-loss medications for $50 a month through 2027. Here’s what the new program means for patients, payers and drugmakers. Learn More GLP-1s are forcing a strategic reset across healthcare: Wells Fargo report GLP-1s are reshaping more than weight management—they’re changing healthcare’s business model. A new Wells Fargo report explores how the drugs could impact hospitals, health plans, service lines and long-term healthcare spending. Read More →